Target intelligence / Profile preview

Major histocompatibility complex class I polypeptide-related sequence A (MICA) and B (MICB) (MICA; MICB)

Target
MICA; MICB
Molecular classification
Ligand, Stress-induced protein, MHC class I-like protein, Cell surface antigen
01

Overview

NKG2D ligands, principally MICA and MICB in humans, are cell-surface glycoproteins induced by cellular stress such as oncogenic transformation, DNA damage, or infection. They serve as activating signals for cytotoxic lymphocytes—especially NK cells and some T cell subsets—through the NKG2D receptor, enabling immune surveillance and elimination of transformed or infected cells. Tumors often evade this immune detection by shedding or downregulating these ligands, leading to immune escape. Targeting this pathway holds promise in cancer immunotherapy, particularly with engineered immune cells that exploit NKG2D ligand recognition to target malignant cells.

Other names
NKG2D ligandstress-induced ligandMICULBP family (ULBP1–6)NKG2DL
02

Mechanism of action

Promotes immune-mediated cytotoxicity via NKG2D receptor activation; involved in immune escape via shedding/cleavage from tumor cell surface.

03

Biological functions

Immune recognitionTumor surveillanceImmune response activationSignal transduction
04

Disease associations

CancerInfection (e.g., viral immune evasion)InflammationAutoimmunity (e.g., celiac disease)
05

Safety considerations

On-target, off-tumor toxicity due to presence of ligands on stressed or diseased normal cellsImmune evasion by tumors via ligand shedding or downregulationAutoimmunity if normal tissue is attacked
06

Interacting drugs

NKG2D ligand-modulating agents (in clinical trials)

1 more in the full profile.

07

Biomarkers

Cell-surface expression of MICA/B or ULBPs as biomarkers for susceptibility to NK or CIK cell-based immunotherapies

Beyond the preview

Go deeper on Major histocompatibility complex class I polypeptide-related sequence A (MICA) and B (MICB) (MICA; MICB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Major histocompatibility complex class I polypeptide-related sequence A (MICA) and B (MICB) (MICA; MICB).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call